DE60331577D1 - Verfahren und produkte - Google Patents

Verfahren und produkte

Info

Publication number
DE60331577D1
DE60331577D1 DE60331577T DE60331577T DE60331577D1 DE 60331577 D1 DE60331577 D1 DE 60331577D1 DE 60331577 T DE60331577 T DE 60331577T DE 60331577 T DE60331577 T DE 60331577T DE 60331577 D1 DE60331577 D1 DE 60331577D1
Authority
DE
Germany
Prior art keywords
products
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60331577T
Other languages
English (en)
Inventor
Praveen Sharma
Narinder Singh Sahni
Anders Loenneborg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagenic AS
Original Assignee
Diagenic AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagenic AS filed Critical Diagenic AS
Application granted granted Critical
Publication of DE60331577D1 publication Critical patent/DE60331577D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Theoretical Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60331577T 2002-11-21 2003-11-21 Verfahren und produkte Expired - Lifetime DE60331577D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0227238.3A GB0227238D0 (en) 2002-11-21 2002-11-21 Product and method
PCT/GB2003/005102 WO2004046382A2 (en) 2002-11-21 2003-11-21 Product and method

Publications (1)

Publication Number Publication Date
DE60331577D1 true DE60331577D1 (de) 2010-04-15

Family

ID=9948301

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60331577T Expired - Lifetime DE60331577D1 (de) 2002-11-21 2003-11-21 Verfahren und produkte

Country Status (19)

Country Link
US (2) US20070134656A1 (de)
EP (1) EP1565574B1 (de)
CN (2) CN1742101A (de)
AP (1) AP2333A (de)
AT (1) ATE459726T1 (de)
AU (1) AU2003286262C1 (de)
CA (1) CA2506887A1 (de)
CY (1) CY1110543T1 (de)
DE (1) DE60331577D1 (de)
DK (1) DK1565574T3 (de)
ES (1) ES2342161T3 (de)
GB (1) GB0227238D0 (de)
HK (1) HK1079554A1 (de)
NO (1) NO20052544L (de)
NZ (1) NZ540750A (de)
PT (1) PT1565574E (de)
SI (1) SI1565574T1 (de)
WO (1) WO2004046382A2 (de)
ZA (1) ZA200503797B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0412301D0 (en) * 2004-06-02 2004-07-07 Diagenic As Product and method
GB0422211D0 (en) * 2004-10-06 2004-11-03 Randox Lab Ltd Method
FR2900936B1 (fr) * 2006-05-15 2013-01-04 Exonhit Therapeutics Sa Procede et methodes de detection de la maladie d'alzheimer
US9995766B2 (en) * 2009-06-16 2018-06-12 The Regents Of The University Of California Methods and systems for measuring a property of a macromolecule
GB201000688D0 (en) 2010-01-15 2010-03-03 Diagenic Asa Product and method
WO2013064702A2 (en) 2011-11-03 2013-05-10 Diagenic Asa Probes for diagnosis and monitoring of neurodegenerative disease
US10339527B1 (en) 2014-10-31 2019-07-02 Experian Information Solutions, Inc. System and architecture for electronic fraud detection
US10140708B2 (en) * 2016-01-21 2018-11-27 Riverside Research Institute Method for gestational age estimation and embryonic mutant detection
CN110669830B (zh) * 2019-10-24 2023-05-23 裕策医疗器械江苏有限公司 一种低质量ffpe dna的处理方法、装置和存储介质

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981783A (en) * 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US5871928A (en) * 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
US5925525A (en) * 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5633137A (en) * 1992-12-01 1997-05-27 The University Of South Florida Method for measuring specific gene expression: transcriptional activity per gene dose
US5677125A (en) * 1994-01-14 1997-10-14 Vanderbilt University Method of detection and diagnosis of pre-invasive cancer
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5545531A (en) * 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US5994076A (en) * 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
US6607879B1 (en) * 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
US6004755A (en) * 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20040265869A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of type II diabetes related gene transcripts in blood
US20050003394A1 (en) * 1999-01-06 2005-01-06 Chondrogene Limited Method for the detection of rheumatoid arthritis related gene transcripts in blood
US20040241727A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of schizophrenia related gene transcripts in blood
US20040241728A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
US7473528B2 (en) * 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US20040248169A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of obesity related gene transcripts in blood
US20040248170A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of hyperlipidemia related gene transcripts in blood
US20040265868A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of depression related gene transcripts in blood
US20050042630A1 (en) * 1999-01-06 2005-02-24 Chondrogene Limited Method for the detection of asthma related gene transcripts in blood
WO2000040749A2 (en) * 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
WO2002059271A2 (en) * 2001-01-25 2002-08-01 Gene Logic, Inc. Gene expression profiles in breast tissue
US20020169560A1 (en) * 2001-05-12 2002-11-14 X-Mine Analysis mechanism for genetic data

Also Published As

Publication number Publication date
DK1565574T3 (da) 2010-06-21
CN102191319A (zh) 2011-09-21
EP1565574B1 (de) 2010-03-03
HK1079554A1 (en) 2006-04-07
US20070134656A1 (en) 2007-06-14
CY1110543T1 (el) 2015-04-29
AU2003286262A1 (en) 2004-06-15
GB0227238D0 (en) 2002-12-31
ZA200503797B (en) 2006-11-29
EP1565574A2 (de) 2005-08-24
WO2004046382A3 (en) 2004-07-22
CA2506887A1 (en) 2004-06-03
ATE459726T1 (de) 2010-03-15
AU2003286262C1 (en) 2008-09-18
US20130143761A1 (en) 2013-06-06
ES2342161T3 (es) 2010-07-02
AP2005003317A0 (en) 2005-06-30
CN1742101A (zh) 2006-03-01
PT1565574E (pt) 2010-06-07
AU2003286262B2 (en) 2008-02-21
NO20052544L (no) 2005-06-20
WO2004046382A2 (en) 2004-06-03
AP2333A (en) 2011-12-06
NZ540750A (en) 2008-07-31
SI1565574T1 (sl) 2010-07-30

Similar Documents

Publication Publication Date Title
DE60317268D1 (de) Verfahren zum extrudieren von brotteig und danach erhältliche produkte
ATE458473T1 (de) Missbrauchssichere opioid-freisetzende produkte
DE60310339D1 (de) Querträger und Herstellungsverfahren
DE60327225D1 (de) Aripiprazol-komplex-formulierung und verfahren
ATE373183T1 (de) Treibriemen und verfahren
DE60212580D1 (de) Ortungssystem und Verfahren
DE60324888D1 (de) und Herstellungsverfahren
DE602004021802D1 (de) Heisspressgeformtes produkt und herstellungsverfahren dafür
DE60319810D1 (de) Anschwemmfiltermedien und herstellungs- und verwendungsverfahren
DE60335738D1 (de) Mehrfach-ausrichteverfahren und vorrichtung
DE602005002927D1 (de) Zeitsynchronisierungseinrichtung und -verfahren und entsprechende produkte
DE60311063D1 (de) Ausziehleiter und zugehörige herstellungsverfahren
DE60317699D1 (de) Fermentationsverfahren und -zusammensetzungen
DE60332996D1 (de) Verriegelbarer warenauslagehaken
DE60331729D1 (de) Audiocodierungsverfahren und audiocodierungseinrichtung
ATE555078T1 (de) Verfahren und zwischenprodukte
DE60228044D1 (de) Verteiltes Rechnersystem und Verfahren
DE60309411D1 (de) Pollensensor und Verfahren
DE60208700D1 (de) Schälgerät und zugehörige verfahren
DE60219261D1 (de) Lageranordnung und Verfahren
DE60333155D1 (de) Simultandolmetschen- System und Verfahren
FI20010075A (fi) Terveysvaikutteinen tuote ja menetelmä
DE60331577D1 (de) Verfahren und produkte
DE60302717D1 (de) Temperaturkompensierte Aufblasvorrichtung und Methode
DE60317443D1 (de) H-Brückenvorrichtung und Verfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition